Roche hands NYC a biotech coup with new R&D site

So long, Nutley. Hello, Big Apple. Roche ($RHHBY) is moving its whittled-down East Coast R&D group from New Jersey to a new life sciences complex in Manhattan, which beat out some fierce competition for one of the biggest U.S. economic development deals in biotech this year. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.